Additionally, we assessed the therapeutic potential of adeno‐associated virus 9 (AAV9)‐mediated Senp1 gene delivery in improving cardiac pathology and reversing postischemic heart failure in a preclinical model of heart failure. The gene discussed is SENP1; the disease is heart failure.